Stock 002873 GUIYANG XINTIAN PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Guiyang Xintian Pharmaceutical Co.,Ltd.

Equities

002873

CNE100002QB5

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 14/05/2024 BST 		5-day change 1st Jan Change
11.77 CNY -1.67% Intraday chart for Guiyang Xintian Pharmaceutical Co.,Ltd. -3.52% -5.54%
04-27 Guiyang Xintian Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-11 Guiyang Xintian Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Guiyang Xintian Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research, development, production and sales of Chinese patent drugs. The Company manufactures its products in the forms of capsules, mixture, granules, syrup, gel and tablets. The Company’s main products include Ningmitai Capsule, Kuntai Capsule, Kushen Gel and Xiaokucao Oral Liquid .The Company distributes its products in the domestic market.

Number of employees: 1,958

Sales per Business

CNY in Million2022Weight2023Weight Delta
Gynecology
70.8 %
769 70.7 % 676 70.8 % -12.08%
Urinary System
20.1 %
222 20.4 % 191 20.1 % -13.78%
Heat-clearing and Detoxification
8.5 %
80 7.4 % 81 8.5 % +1.11%
Other
0.6 %
16 1.5 % 6 0.6 % -64.16%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
1,088 100.0 % 954 100.0 % -12.29%

Managers

Managers TitleAgeSince
Da Lun Dong CEO
 Chief Executive Officer 60 10/08/95
Zhi Hui Zeng DFI
 Director of Finance/CFO 51 31/01/18
Zhong Lei He BRD
 Director/Board Member 47 31/03/21
Guang Ping Wang BRD
 Director/Board Member 54 25/08/20
Jin Hua Wang BRD
 Director/Board Member 57 10/08/95
Wei Wang IRC
 Investor Relations Contact - -
Jue Rong Chen PRN
 Corporate Officer/Principal 55 31/03/06

Members of the board

Members of the board TitleAgeSince
Da Lun Dong CEO
 Chief Executive Officer 60 10/08/95
Jin Hua Wang BRD
 Director/Board Member 57 10/08/95
Jue Rong Chen PRN
 Corporate Officer/Principal 55 31/03/06
Jie Zhang BRD
 Director/Board Member 50 14/09/21
Weijia Ji BRD
 Director/Board Member 46 18/04/19
Wan Xue An CHM
 Chairman 49 11/11/19
Ruzhen Jin BRD
 Director/Board Member 54 11/11/19
Feng Guan BRD
 Director/Board Member 42 14/09/21
Zhong Lei He BRD
 Director/Board Member 47 31/03/21
Li Jin Gao BRD
 Director/Board Member 53 24/08/23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 246,677,785 134,244,413 ( 54.42 %) 15,138,117 ( 6.137 %) 54.42 %

Shareholders

NameEquities%Valuation
Rongtong Fund Management Co., Ltd.
5.735 %
12,699,940 5.735 % 21 M ¥
Hotland Innovation Asset Management Co. Ltd.
2.046 %
4,530,600 2.046 % 7 M ¥
Zhong Geng Fund Management Co. , Ltd.
1.661 %
3,678,780 1.661 % 6 M ¥
China Fund Management Co., Ltd.
0.4164 %
922,200 0.4164 % 2 M ¥
AXA-SPDB Investment Managers Co., Ltd.
0.3763 %
833,415 0.3763 % 1 M ¥
Essence Fund Co., Ltd.
0.3147 %
696,908 0.3147 % 1 M ¥
China Southern Asset Management Co., Ltd.
0.2349 %
520,100 0.2349 % 855 403 ¥
Soochow Asset Management Co., Ltd.
0.1662 %
368,100 0.1662 % 605 410 ¥
Tian Hong Asset Management Co., Ltd.
0.1174 %
260,080 0.1174 % 427 751 ¥
ICBC Credit Suisse Asset Management Co., Ltd.
0.0948 %
209,900 0.0948 % 345 220 ¥

Company contact information

Guiyang Xintian Pharmaceutical Co., Ltd.

3 Gaoxin North Road Wudang District

550000, Guiyang

+

http://www.gyxtyy.com
address Guiyang Xintian Pharmaceutical Co.,Ltd.(002873)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Specialty & Advanced Pharmaceuticals

Sales per Business

Ratings for Guiyang Xintian Pharmaceutical Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
11.77
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
GUIYANG XINTIAN PHARMACEUTICAL CO.,LTD. Stock Guiyang Xintian Pharmaceutical Co.,Ltd.
-5.54% 381M
MERCK KGAA Stock Merck KGaA
+15.09% 74.45B
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+11.35% 9.18B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+54.35% 5.03B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-12.85% 5.02B
YUHAN CORPORATION Stock Yuhan Corporation
+1.60% 3.82B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-20.85% 2.41B
INDIVIOR PLC Stock Indivior PLC
+16.88% 2.39B
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-29.25% 2.27B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+24.62% 2.26B
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002873 Stock
  4. Company Guiyang Xintian Pharmaceutical Co.,Ltd.